NCT00127387 Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia Status TERMINATED Phase PHASE2/PHASE3
NCT00127088 Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients Status SUSPENDED Phase PHASE2
NCT00126815 Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy Status COMPLETED Phase N/A
NCT00126802 The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT00126230 Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer Status TERMINATED Phase PHASE2
NCT00126165 Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00124917 Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer Status TERMINATED Phase PHASE1
NCT00124566 Study of Irofulven in Patients With Hormone-refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00124410 Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation Status COMPLETED Phase N/A
NCT00123838 Positioning and Tracking the Prostate During External Beam Radiation Status COMPLETED Phase NA
NCT00122499 A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer Status COMPLETED Phase PHASE3
NCT00122265 Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer Status TERMINATED Phase N/A
NCT00122252 Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose Escalation Status TERMINATED Phase N/A
NCT00122239 A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers Status UNKNOWN Phase N/A
NCT00122005 GVAX in Advanced Prostate Cancer Patients Made Lymphopenic Status UNKNOWN Phase PHASE1/PHASE2
NCT00118066 Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia Status TERMINATED Phase PHASE2
NCT00117949 Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486 Status COMPLETED Phase PHASE2
NCT00117312 Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients Status TERMINATED Phase PHASE2